drugset / Trial / NCT02172222
Relative Bioavailability of BI 10773 and Linagliptin in Healthy Male Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
Study to investigate the relative bioavailability of BI 10773 and of linagliptin after concomitant multiple oral administration of 50 mg BI 10773 tablets and 5 mg linagliptin in comparison to 50 mg BI 10773 and 5 mg linagliptin given alone.
Timeline
- Start
- 2009-07
- Primary completion
- 2009-09
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 50 mg | Oral |
| Subject | Linagliptin | Small molecule | 5 mg | Oral |
Indications
No indication recorded.